cjc 1295 ipamorelin clinical evidence safety CJC-1295/Ipamorelin for Women: GH Therapy After 35 CJC-1295 and Ipamorelin Benefits, Risks,

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider a pharmacogenomic foundation before the first prescription is written

What ipamorelin does not raise Unlike GHRP-2 and GHRP-6, ipamorelin did not raise cortisol (a stress hormone), ACTH , or prolactin in lab testing at standard GH-releasing doses (Raun et al

Important Disclaimer: This peptide blend is not intended for diagnostic, therapeutic, or clinical applications

Key properties: Stimulates GH release from the pituitary (not the hypothalamus) Does not significantly raise cortisol or prolactin Short half-life (~2 hours) produces a sharp, pulsatile GH release Does not block somatostatin (the hormone that inhibits GH release) Selective for GH minimal effect on other hormones The selectivity is what makes ipamorelin the preferred GHRP for most protocols

The medical profiling will be second to none